Optional Revascularization Strategies for Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Disease.

Autor:	Zhong PY; Department of Cardiology, Nanchong Central Hospital (Nanchong Hospital of Beijing Anzhen Hospital/The Second Clinical College of North Sichuan Medical College), 637000 Nanchong, Sichuan, China., Sun B; Department of Cardiology, Nanchong Central Hospital (Nanchong Hospital of Beijing Anzhen Hospital/The Second Clinical College of North Sichuan Medical College), 637000 Nanchong, Sichuan, China., Cao HP; Department of Cardiology, Nanchong Central Hospital (Nanchong Hospital of Beijing Anzhen Hospital/The Second Clinical College of North Sichuan Medical College), 637000 Nanchong, Sichuan, China., Wang W; Department of Cardiology, Nanchong Central Hospital (Nanchong Hospital of Beijing Anzhen Hospital/The Second Clinical College of North Sichuan Medical College), 637000 Nanchong, Sichuan, China., Xiong TL; Department of Cardiology, Nanchong Central Hospital (Nanchong Hospital of Beijing Anzhen Hospital/The Second Clinical College of North Sichuan Medical College), 637000 Nanchong, Sichuan, China.
Jazyk:	angličtina
Zdroj:	Reviews in cardiovascular medicine [Rev Cardiovasc Med] 2024 Jun 04; Vol. 25 (6), pp. 209. Date of Electronic Publication: 2024 Jun 04 (Print Publication: 2024).
DOI:	10.31083/j.rcm2506209
Abstrakt:	Percutaneous coronary intervention is the main strategy of revascularization and has been shown to improve outcomes in some patients with ST-segment elevation myocardial infarction (STEMI). However, multivessel disease (MVD), a common condition in these patients, is associated with worse clinical outcomes compared to single-vessel disease. Despite intervention being a standard treatment for coronary artery disease, optimal strategies and timings for patients with STEMI and MVD remain unclear. Numerous studies and meta-analyses have investigated this topic; however, many current conclusions are based on observational studies. Furthermore, clinical guidelines regarding the management of patients with STEMI and MVD contain conflicting recommendations. Therefore, we aimed to compile relevant studies and newly available evidence-based medicines to explore the most effective approach. Competing Interests: The authors declare no conflict of interest. (Copyright: © 2024 The Author(s). Published by IMR Press.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu